From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology
Clinical Pharmacology & Therapeutics · 2026-05 · 119 (5) · 1121-1125
DOI: 10.1002/cpt.70272 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 15.04.2026. Verfasst von Karen Rowland Yeo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Certara UK Ltd, Sheffield, UK. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Certara UK Ltd, Sheffield, UK.
- Gates Foundation, Seattle, Washington, USA.
- Department of Women's and Children's Health, School of Medicine, University of Liverpool, Liverpool, UK.
- Infectious Diseases Institute, Makerere University, Kampala, Uganda.
ORCID-Profile: Karen Rowland Yeo, Catriona Waitt
Zitieren
APA
Rowland Yeo, K., Hartman, D., & Waitt, C. (2026). From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology. Clinical Pharmacology & Therapeutics, 119(5), 1121-1125. https://doi.org/10.1002/cpt.70272
Vancouver
Rowland Yeo K, Hartman D, Waitt C. From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology. Clinical Pharmacology & Therapeutics. 2026;119(5):1121-1125. doi:10.1002/cpt.70272
BibTeX
@article{RowlandYeo2026,
author = {Rowland Yeo, Karen and Hartman, Dan and Waitt, Catriona},
title = {From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology},
journal = {Clinical Pharmacology & Therapeutics},
year = {2026},
volume = {119},
number = {5},
pages = {1121--1125},
doi = {10.1002/cpt.70272}
}
EUVIMED